Concepedia

Rachel Washart

RW

Statistics

Publications

3

Citations

105

H-Index

3

Active since

2022

Affiliations

Duke University(Current)

Rachel Washart is an author at Duke University specializing in oncology, apoptosis, and apoptotic signaling.

ORCID

Publications per year

2022–2023

3

Publications

3

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia

Kevin Lin, Justine C. Rutter, Abigail Xie et al. · Nature Cancer · 2022 · 42 citations · Full text

, , +16

Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis

Shane T. Killarney, Rachel Washart, Ryan S. Soderquist et al. · Nature Communications · 2023 · 36 citations · Full text

, , +14

Drug dependence in cancer is exploitable by optimally constructed treatment holidays

Jeff Maltas, Shane T. Killarney, Katherine R. Singleton et al. · Nature Ecology & Evolution · 2023 · 27 citations · Full text

, , +8

1–3 of 3